Clark Capital Management Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$8.09M	Buy	71,133 +27,079	+61%	+$3.08M	0.06%	168
2025 Q1	$4.63M	Buy	44,054 +6,777	+18%	+$713K	0.03%	202
2024 Q4	$3.99M	Buy	37,277 +11,456	+44%	+$1.23M	0.03%	217
2024 Q3	$2.58M	Buy	+25,821	New	+$2.58M	0.02%	237